Additional file 3 of Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses

Additional file 3: Supplementary Table 1. Clinicopathological information and survival status of the NSCLC patients enrolled for ptPDX (N = 10) and CDX (N = 2) model development. Supplementary Table 2. Total counts of ptPDX individual CTCs and CTC clusters that were detected at the time of injection to naïve NSG mice to develop CDX models.